After the dichotomization of the patient cohort based on the median of the percentage of GLUT-1high tumor cells in the tumor compartment, a significantly better prognosis was found for patients with a smaller fraction of GLUT-1high tumor cells, i.e., for patients with better-oxygenated tumors. The gene discussed is SLC2A1; the disease is neoplasm.